Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- Universidade de Vigo
- University of A Coruña
- ICN2
- UNIVERSIDAD DE LAS PALMAS DE GRAN CANARIA
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- IMDEA Networks Institute
- CSIC
- Fundació per a la Universitat Oberta de Catalunya
- Universidad Carlos III de Madrid
- Universitat Autònoma de Barcelona
- Agency for Management of University and Research Grants (AGAUR)
- Centro Nacional de Investigaciones Cardiovasculares Carlos III F.S.P.
- DENA DESARROLLOS SL
- European Magnetism Association EMA
- European Molecular Biology Laboratory (EMBL)
- FUNDACIO INSTITU DE RECERCA EN ENERGIA DE CATALUNYA
- FUNDACIÓN CANARIA PARQUE CIENTÍFICO TECNOLÓGICO
- Fundació Privada I2CAT
- Fundación IMDEA Nanociencia
- Fundación de investigación HM Hospitales
- IRTA
- Institut Català d'Arqueologia Clàssica
- Institute of Chemical Research of Catalonia ICIQ
- Iquadrat Informatica SL
- Josep Carreras Leukaemia Research Institute (IJC)
- Nature Careers
- UNIVERSIDAD DE BURGOS
- UNIVERSIDAD EUROPEA
- Universitat Politècnica de València
- 19 more »
- « less
-
Field
-
deployment of this technology. Responsibilities The successful candidate will contribute to ongoing research projects in cryptography and privacy, performing the following tasks within a cutting-edge research
-
previously hired in the form of a PhD contract, the duration of the contract may not exceed the maximum established in Article 21.c) of Law 14/2011, of 1 June, on Science, Technology and Innovation. Number
-
year duration, extendable up to a maximum of 4 years, in accordance with Article 21 of the Law on Science, Technology and Innovation (consolidated text of Law 14/2011, of June 1, on Science, Technology
-
The Science and Technology Park Foundation (FCPCT) of the University of Las Palmas de Gran Canaria (ULPGC) - Spain offers one PhD researcher position (ICP1 MECES 4) to work in the EU BLUEGREEN GOVERNANCE
-
proteolysis-targeting chimeras (PROTACs). We will benchmark their performance and determine specificity using established reporter cells, engineered primary murine AML cells and a panel of human AML cell lines